The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Colon cancer is now the number one cancer killer in the U.S. of people ages 50 and younger, and yet many folks (at any age) are reluctant to get a colonoscopy -- the gold standard for detection of ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Colon cancer is a leading cause of cancer-related deaths.

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...

There's been a steep increase in colon cancer cases among adults 45 to 49 in recent years, and that's a good thing, experts say. This upsurge means that more colon cancers are being caught at an ...

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...

A major European trial has pushed colonoscopy back into the medical spotlight. After 13 years, the NordICC study found that ...

As of July 1, Ontario will offer publicly funded colorectal cancer (CRC) screening to patients as young as 45 years. Patients ...

Starting next month, Ontarians who are 45 years old will be eligible for colorectal cancer screening. Some patients and ...